Healthcare AI Adoption Outpaces Patient Trust, Study Finds

The automation paradox in patient care

A striking disconnect is emerging in healthcare technology: artificial intelligence now represents 46% of all healthcare investment, approaching $18 billion in 2025, yet the majority of patients report discomfort when providers rely on AI for their care, according to an analysis published in MedCity News.

The gap reveals more than consumer hesitation. It points to a fundamental mismatch between how technology is being deployed and what patients actually need to stay engaged with their care—particularly around medication adherence, which drives more than $500 billion in avoidable U.S. healthcare costs annually.

The disconnect became visible in an unexpected place. In February, Waymo's chief safety officer testified before the U.S. Senate that remote human operators in the Philippines help guide its autonomous vehicles. The revelation underscored a broader truth: even after billions in development, human judgment remains essential in high-stakes automated systems.

Why digital-only interventions fall short

The evidence on purely automated patient engagement is sobering. A systematic review of app-based interventions for chronic disease found that up to 98% of users disengage within a short period or reduce usage to ineffective levels.

The problem isn't technical capability—it's the behavioral model underneath. Patients managing new diagnoses or complex medication regimens aren't making rational calculations. They're navigating fear, confusion, and isolation, emotions that don't respond to better-timed push notifications.

Research consistently shows that patients lacking emotional and instrumental support are significantly more likely to abandon therapy. A 2025 systematic review confirmed that loneliness and lack of support negatively impact medication adherence, with effects that compound over time.

Trust plays an equally central role. A global study found only 51% of respondents trust their healthcare system to deliver optimal care, and multiple studies demonstrate strong correlation between provider trust and improved adherence. Without trust-based communication, patients cannot freely discuss medication concerns, and adherence behavior suffers.

Why it matters

Healthcare organizations are deploying AI faster than they're building the human infrastructure to make it effective. The result isn't just poor user experience—it's measurable clinical and financial harm through medication nonadherence and patient disengagement. Leaders who assume automation alone will solve engagement challenges are likely to see diminishing returns on substantial technology investments.

Where AI actually adds value

AI excels at identifying at-risk patients before they disengage, surfacing behavioral patterns across thousands of interactions, and handling operational work that frees care teams for human connection. These contributions are meaningful when they support rather than replace human touchpoints.

The organizations succeeding aren't defined by automation volume. They're defined by how deliberately they've protected the human interactions that drive trust, engagement, and outcomes.

Questions leaders should ask

When evaluating patient engagement technology, healthcare executives should demand answers to specific questions: What happens when a patient is scared but can't articulate it? Who steps in when the technology reaches its limit, and how quickly? What does engagement look like at six months, not just at launch?

The Waymo example illustrates that some decisions remain too consequential to make without human judgment. In healthcare, nearly every patient decision qualifies.

These details were first reported by Michael Oleksiw, corporate entrepreneur and mission leader at Pleio, writing in MedCity News.